Results 111 to 120 of about 2,440 (155)

Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience. [PDF]

Hum Vaccin Immunother
Vadrevu KM, Chiteti SR, Dugyala R, Aileni VK, Kunta A, Patnaik BN, Ella R.   +6 more
europepmc   +1 more source

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal. [PDF]

Hum Vaccin Immunother, 2023
Chaudhary S, Shah GS, Bhatta NK, Poudel P, Rai B, Uranw S, Tripathi PM, Khanal B, Ghimire A, Rai N, Gupta BP, Vemula S, Wartel TA, Sahastrabuddhe S, Saluja T.   +14 more
europepmc   +1 more source

Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012-19) before typhoid conjugate vaccine roll-out: a genomic epidemiology study.

Lancet Microbe, 2023
Thilliez G, Mashe T, Chaibva BV, Robertson V, Bawn M, Tarupiwa A, Takawira FT, Kock MM, Midzi S, Mwamakamba LW, Matheu J, Juru A, Kingsley RA, Ehlers MM.   +13 more
europepmc   +1 more source

Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe. [PDF]

Vaccine, 2022
Shaum A, Mujuru HA, Takamiya M, Ticklay I, Nathoo K, Sreenivasan N, Nyambayo P, Chitando P, Marembo J, Koline Chigodo C, Mukaratirwa A, Jacha V, Gidudu JF, Rupfutse M, Kumar Jain S, Manangazira P, Bennett SD.   +16 more
europepmc   +1 more source

Cost of the typhoid conjugate vaccine introduction through an integrated campaign and follow-on routine immunization in Malawi. [PDF]

Vaccine X
Debellut F, Bello G, Chisema M, Mkisi R, Kamzati M, Pecenka C, Mugisha E.   +6 more
europepmc   +1 more source

Comparison of Strategies for Typhoid Conjugate Vaccine Introduction in India: A Cost-Effectiveness Modeling Study. [PDF]

J Infect Dis, 2021
Ryckman T, Karthikeyan AS, Kumar D, Cao Y, Kang G, Goldhaber-Fiebert JD, John J, Lo NC, Andrews JR.   +8 more
europepmc   +1 more source

Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign. [PDF]

Am J Trop Med Hyg
Date K, LeBoa C, Hoffman SA, Haldar P, Harvey P, An Q, Zhang C, Yewale VN, Daruwalla S, Dharmapalan D, Gavhane J, Joshi S, Rai R, Rathod V, Shetty K, Warrier DS, Yadav S, Shimpi R, Jayaprasad N, Horng L, Fagerli K, Borhade P, Chakraborty D, Katkar A, Kunwar A, Andrews JR, Bahl S, Bhatnagar P, Dutta S, Luby SP.   +29 more
europepmc   +1 more source

Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. [PDF]

BMJ Public Health
Mogasale VV, Sinha A, John J, Hasan Farooqui H, Ray A, Chantler T, Mogasale V, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K.   +10 more
europepmc   +1 more source

Development status of typhoid conjugate vaccines globally [PDF]

International Journal of Infectious Diseases, 2016
openaire   +1 more source

Safety and immunogenicity of Biological E's typhoid conjugate vaccine TYPHIBEV^Ⓡ concomitantly administered with measles rubella vaccine: a phase IV prospective, multicenter study. [PDF]

IJID Reg
Thuluva S, Matur RV, Gunneri S, Mogulla R, Dhar C, Yerroju V, Balne N, Chakravarthy BS, Narang M, Mahantshetti NS, Pandey AK.   +10 more
europepmc   +1 more source